Literature DB >> 2026589

Purification of a human glucocorticoid receptor gene promoter-binding protein. Production of polyclonal antibodies against the purified factor.

S Leclerc1, B X Xie, R Roy, M V Govindan.   

Abstract

The glucocorticoid receptor (GR) is an essential protein involved in mediating glucocorticoid-regulated gene transcription. The cellular GR concentration is modulated by a number of factors including glucocorticoids, which are capable of down-regulating their own receptor concentration. To further study this phenomenon, the human GR (hGR) gene promoter was isolated and was shown to contain the sequences essential for glucocorticoid-dependent down-regulation in CV-1 cells by gene transfer. Further transfections performed with the hGR gene demonstrated that the nucleotide sequence between -250 and -750 is implicated in the down-regulation of the hGR by hormone. The promoter region of human GR is extremely rich in G+C sequences which are known to be involved in the regulation of many housekeeping genes such as GR, as well as a number of cellular oncogenes. Using a combination of partial purification of DNA-binding proteins, DNA-protein interaction by gel shift analysis and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis, we have identified a protein factor (GRF-1) of 95 kDa which interacts with the human GR gene fragment implicated in homologous down-regulation. Polyclonal antibodies were then raised against the protein following purification. This method of purification and identification may be universally applied to purify and characterize unknown factors which may be involved in the regulation of genes such as hGR gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026589

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

2.  Attenuation of glucocorticoid receptor levels by the H-ras oncogene.

Authors:  V R Martins; M M Brentani; P R Housley
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

3.  Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.

Authors:  Stephen T Magill; Charlotte D Eaton; Abrar Choudhury; Briana C Prager; William C Chen; Martha A Cady; Kyounghee Seo; Calixto-Hope G Lucas; Tim J Casey-Clyde; Harish N Vasudevan; S John Liu; Javier E Villanueva-Meyer; Tai-Chung Lam; Jenny Kan-Suen Pu; Lai-Fung Li; Gilberto Ka-Kit Leung; Danielle L Swaney; Michael Y Zhang; Jason W Chan; Zhixin Qiu; Michael V Martin; Matthew S Susko; Steve E Braunstein; Nancy Ann Oberheim Bush; Jessica D Schulte; Nicholas Butowski; Penny K Sneed; Mitchel S Berger; Nevan J Krogan; Arie Perry; Joanna J Phillips; David A Solomon; Joseph F Costello; Michael W McDermott; Jeremy N Rich; David R Raleigh
Journal:  Nat Genet       Date:  2022-05-09       Impact factor: 41.307

4.  Recruitment of cAMP-response element-binding protein and histone deacetylase has opposite effects on glucocorticoid receptor gene transcription.

Authors:  Manjapra Variath Govindan
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

5.  Regulation of the glucocorticoid receptor gene by the AP-1 transcription factor.

Authors:  P Wei; W V Vedeckis
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

6.  A distal activation domain is critical in the regulation of the rat androgen receptor gene promoter.

Authors:  C S Song; S Her; M Slomczynska; S J Choi; M H Jung; A K Roy; B Chatterjee
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

7.  The distribution of SNPs in human gene regulatory regions.

Authors:  Yongjian Guo; D Curtis Jamison
Journal:  BMC Genomics       Date:  2005-10-06       Impact factor: 3.969

8.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.